Stephens Consulting, LLC - AIM IMMUNOTECH INC ownership

AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 39 filers reported holding AIM IMMUNOTECH INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Stephens Consulting, LLC ownership history of AIM IMMUNOTECH INC
ValueSharesWeighting
Q1 2023$645
+37.8%
1,5000.0%0.00%
Q4 2022$468
-46.4%
1,5000.0%0.00%
-100.0%
Q3 2022$873
-25.4%
1,5000.0%0.00%0.0%
Q2 2022$1,170
-26.4%
1,5000.0%0.00%0.0%
Q1 2022$1,590
-42.4%
1,500
-50.0%
0.00%
-50.0%
Q4 2021$2,7603,0000.00%
Other shareholders
AIM IMMUNOTECH INC shareholders Q4 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 528,811$288,0000.08%
Jacobi Capital Management LLC 2$00.00%
HUNTINGTON NATIONAL BANK 57$00.00%
BANK OF AMERICA CORP /DE/ 3,239$2,0000.00%
CITY HOLDING CO 10$00.00%
CREDIT AGRICOLE S A 1$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
DEUTSCHE BANK AG\ 4,347$2,0000.00%
MORGAN STANLEY 76$00.00%
BANK OF MONTREAL /CAN/ 5$00.00%
View complete list of AIM IMMUNOTECH INC shareholders